
Chemxlnc Pharma Private Limited
About Chemxlnc Pharma Private Limited
Data last updated:
Chemxlnc Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC319025. Its GSTIN is 27AAHCC9400A1Z3 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kirtida Vikram Shah and Shivali Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D/211 Samruddhi M.G. Road Kandivali West, Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.13 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹16.61 Lakh (net margin 2.3%) and EBITDA of ₹17.63 Lakh (EBITDA margin 2.5%).
Chemxlnc Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0110788).
Company details
Recognitions & Rankings of Chemxlnc Pharma
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0110788
Contact details
Chemxlnc Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD/211 Samruddhi M.G. Road Kandivali West, Mumbai, Maharashtra, India – 400067
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Chemxlnc Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Chemxlnc Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Chemxlnc Pharma Private Limited, buy the company report.
Financials of Chemxlnc Pharma Private Limited
FY 2024 filings availableChemxlnc Pharma Private Limited reported revenue of ₹7.13 Cr (up 375% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 375% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chemxlnc Pharma Private Limited, buy the company report.
Board of directors of Chemxlnc Pharma Private Limited
Chemxlnc Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirtida Vikram Shah | Director | 03 Jan 2019 | 7 Years 10 Months | Current |
| Shivali Shah | Director | 03 Jan 2019 | 7 Years 10 Months | Current |
Peer comparison
Chemxlnc Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Retec Healthcare Private Limited | ₹7.17 Cr (FY 2025) | 58.0% | New Delhi, Delhi, India | |||
| MDC Exports Private Limited | ₹7.17 Cr (FY 2024) | -33.0% | Delhi, India | |||
| Chemxlnc Pharma Private Limitedthis company | ₹7.13 Cr (FY 2023) | ₹16.61 Lakh | 2.3% | 375.0% | Mumbai, Maharashtra, India | |
| Benmed Pharma Private Limited | ₹7.11 Cr (FY 2024) | 59.0% | Ambala, Haryana, India | |||
| Lewis Pharmaceuticals Private Limited | ₹7.09 Cr (FY 2025) | 9.0% | Surat, Gujarat, India |
To see the full peer comparison of Chemxlnc Pharma Private Limited, buy the company report.
Auditor
Chemxlnc Pharma Private Limited is audited by NIKUNJ J SHAH & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIKUNJ J SHAH & ASSOCIATES | FY 2022 | 131638W |
Shareholding
The shareholding of Chemxlnc Pharma Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Chemxlnc Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Chemxlnc Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Chemxlnc Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Chemxlnc Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCC9400A1Z3 | Maharashtra | Active | 04 May 2021 |
To see the full GST registrations and return filing status of Chemxlnc Pharma Private Limited, buy the company report.
Recent activity
Chemxlnc Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Kirtida Vikram Shah was appointed as Director on 03 Jan 2019.
Frequently asked questions
Chemxlnc Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U24304MH2019PTC319025.
Chemxlnc Pharma has 2 current directors:
- Kirtida Vikram Shah - Director
- Shivali Shah - Director
The latest financial statements of Chemxlnc Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Chemxlnc Pharma is 27AAHCC9400A1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Chemxlnc Pharma is U24304MH2019PTC319025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemxlnc Pharma was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Chemxlnc Pharma by revenue are Retec Healthcare Private Limited, MDC Exports Private Limited, Benmed Pharma Private Limited, Lewis Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kirtida Vikram Shah was appointed as Director on 03 Jan 2019. Shivali Shah was appointed as Director on 03 Jan 2019.
Yes, Chemxlnc Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Chemxlnc Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0110788).
The registered office of Chemxlnc Pharma is at D211 Samruddhi M.G. Road Kandivali West, Mumbai, Maharashtra, India – 400067.

